Coya Therapeutics, Inc. Common Stock (COYA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $73.42M
Last updated: Nov 17, 2026 at 11:04 AM ET
Coya Therapeutics, Inc. Common Stock (COYA) Earnings: Report Dates and Results
Coya Therapeutics, Inc. Common Stock (COYA) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Coya Therapeutics, Inc. Common Stock reported EPS of -$0.45, below the -$0.35 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
COYA has an expected report date of Mar 15, 2027.
Earnings History
Of the 15 quarters below that had an estimate, COYA beat 9 and missed 6. Revenue for the quarter ended Sep 30, 2026 was $234134, down 93.4% from $3.56M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.45 | -$0.35 | -$0.37 - -$0.33 | -28.57% | Miss | N/A | 3 | 2 up, 0 down | Nov 10, 2026 | $234134 |
| Jun 30, 2026 | -$0.28 | -$0.36 | -$0.37 - -$0.36 | +22.22% | Beat | N/A | 4 | 1 up, 1 down | Aug 11, 2026 | $243745 |
| Mar 31, 2026 | -$0.32 | -$0.69 | N/A | +53.87% | Beat | N/A | 3 | 0 up, 2 down | May 12, 2026 | $251147 |
| Dec 31, 2025 | -$0.34 | -$0.30 | -$0.43 - -$0.08 | -13.33% | Miss | N/A | 4 | 2 up, 0 down | Mar 16, 2026 | $3.96M |
| Sep 30, 2025 | -$0.13 | -$0.30 | -$0.43 - $0.02 | +56.67% | Beat | N/A | 4 | 1 up, 0 down | Nov 12, 2025 | $3.56M |
| Jun 30, 2025 | -$0.36 | -$0.43 | -$0.47 - -$0.40 | +16.28% | Beat | N/A | 3 | 1 up, 1 down | Aug 12, 2025 | $163616 |
| Mar 31, 2025 | -$0.44 | -$0.12 | -$0.22 - -$0.03 | -266.67% | Miss | N/A | 2 | 0 up, 0 down | May 13, 2025 | $257884 |
| Dec 31, 2024 | -$0.18 | -$0.40 | N/A | +55.00% | Beat | -220.0% | 1 | 0 up, 0 down | Mar 18, 2025 | $1952 |
| Sep 30, 2024 | -$0.26 | -$0.41 | -$0.47 - -$0.31 | +36.59% | Beat | N/A | 4 | 0 up, 0 down | Nov 6, 2024 | N/A |
| Jun 30, 2024 | -$0.19 | -$0.14 | -$0.14 - -$0.14 | -35.71% | Miss | N/A | 1 | 0 up, 0 down | Aug 12, 2024 | $3.43M |
| Mar 31, 2024 | -$0.35 | -$0.29 | N/A | -20.69% | Miss | N/A | 1 | 0 up, 0 down | May 9, 2024 | $126838 |
| Dec 31, 2023 | $0.15 | $0.26 | $0.26 - $0.26 | -42.31% | Miss | N/A | 1 | 0 up, 0 down | Mar 19, 2024 | $6.00M |
| Sep 30, 2023 | -$0.34 | -$0.37 | -$0.37 - -$0.37 | +8.11% | Beat | N/A | 1 | 0 up, 0 down | Nov 8, 2023 | N/A |
| Jun 30, 2023 | -$0.31 | -$0.32 | -$0.33 - -$0.31 | +3.13% | Beat | N/A | 2 | 0 up, 0 down | Aug 8, 2023 | N/A |
| Mar 31, 2023 | -$0.28 | -$0.43 | -$0.43 - -$0.43 | +34.88% | Beat | N/A | 1 | 0 up, 0 down | May 10, 2023 | N/A |
| Dec 31, 2022 | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2023 | N/A |
| Sep 30, 2022 | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 30, 2022 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.27, after -$0.98 the year before. It was -$0.51 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.27 | N/A |
| Dec 31, 2024 | -$0.98 | N/A |
| Dec 31, 2023 | -$0.78 | N/A |
| Dec 31, 2022 | -$0.51 | N/A |
Frequently Asked Questions About COYA
When is Coya Therapeutics, Inc. Common Stock's next earnings date?
Coya Therapeutics, Inc. Common Stock's next earnings report is expected for Mar 15, 2027.
Did COYA beat earnings estimates last quarter?
No. Coya Therapeutics, Inc. Common Stock reported EPS of -$0.45 for the quarter ended Sep 30, 2026, below the -$0.35 estimate by 28.57%.
What EPS do analysts expect from COYA next quarter?
The consensus EPS estimate for Coya Therapeutics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.40 from 9 analysts, with estimates from -$0.49 to -$0.33.
How often does COYA beat earnings estimates?
Coya Therapeutics, Inc. Common Stock beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -13.07%.
COYA pages: Overview, Earnings, Forecast, Financials, Competitors